Mount Sinai scientists identified tiny blood particles called SECmeres that carry brain‑specific RNA and outperformed standard extracellular vesicles as potential Alzheimer’s biomarkers.

Pfizer announced that CFO Dave Denton will step down Aug. 15; Cecile Guegan will serve as interim CFO while the company launches a search for a successor. The move follows several major deals that reshaped Pfizer’s balance sheet.

Federal prosecutors say LangInnov settled after allegedly performing SBIR‑funded R&D overseas, a possible breach of NSF rules. The U.S. Attorney’s office framed the move as enforcement of domestic R&D requirements.

Albany approved S9051 this week to bar AI chatbot features that can harm or manipulate kids; the move was driven by parents testimony and advocacy groups.

Flourish surfaced from stealth with $500M and a $2.5B valuation, backed by Bezos and top VCs, promising a low‑power 'Cortex AI' that blends neuroscience and machine learning.

Columbia researchers report precise base edits in early human embryos, targeting PCSK9 and HBG. Experts warn mosaicism and long‑term safety risks remain.

Justice Department files show Jeffrey Epstein deposited sperm with California Cryobank and signed a 2016 contract leaving the samples to his estate; the material’s whereabouts remain unclear.

Updated CHORD trial numbers presented in Seoul suggest most children with otoferlin‑related deafness gained meaningful hearing after Otarmeni treatment. The therapy was FDA‑cleared in April.

Columbia researchers identify SIRT1 as a driver of treatment‑resistant neuroendocrine prostate cancer and show blocking it halts tumors in mice.

DFS told banks, insurers and crypto firms to tighten authentication, accelerate patching and test backups amid concerns that frontier AI and geopolitical shocks could raise cyber risk.

Mastercard won a New York BitLicense on May 27, giving it regulated footing to expand stablecoin and tokenized‑payment services under state supervision.

Cette AI founder Michael LaFave alleges Voya Financial accessed his devices, stole code and tracked him, a New York lawsuit says.

NYC‑based Runway hit No. 45 on CNBC's Disruptor 50 after a $315M Series E and major product and compute moves that pushed its valuation toward $5.3B.